Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.82 |
| ▸ | RAB9A | P51151 | 3/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | MMP1 | P03956 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MGLL | Q99685 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27950703 | 0.96 | MAPT (0.78) | MAPTRAB9ANPC1CASP1TP53 | |
| SCHEMBL1988905 | 0.96 | MAPT (0.77) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL3052051 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL302596 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL302793 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL7171003 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL3051371 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL12113908 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL21908583 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR | |
| SCHEMBL3055019 | 0.95 | MAPT (0.74) | MAPTRAB9ANPC1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109096420-B | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-119661470-A | Thiadiazole urea compound or pharmaceutically acceptable salt thereof, pharmaceutical composition and application thereof | 安徽医科大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-114945070-A | Motor, camera module and electronic equipment | 维沃移动通信有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-108456157-B | 1-substituted benzoyl-4-fatty acyl semicarbazide derivatives, preparation method and application as antibacterial drugs | 中国医学科学院药物研究所 | 2021-07-20 | — | — | CN | disclosed |
| CN-109096420-B | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-110272364-A | 1- substituted benzoyl -4- fatty acyl group amino carbamide derivative, preparation method and the purposes as antibacterials | 中国医学科学院药物研究所 | 2019-09-24 | — | — | CN | disclosed |
| CN-108456157-A | 1- substituted benzoyl -4- fatty acyl group amino carbamide derivative, preparation method and the purposes as antibacterials | 中国医学科学院药物研究所 | 2018-08-28 | — | — | CN | disclosed |
| US-9939555-B2 | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DIC CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9939555-B2 | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DIC CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| WO-2010057121-A1 | PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS | AMGEN INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| CN-1788008-A | 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists | MERCK & CO INC (US) | 2006-06-14 | — | — | CN | disclosed |
| EP-0852028-B1 | BLACK-AND-WHITE PHOTOTHERMOGRAPHIC AND THERMOGRAPHIC ELEMENTS COMPRISING HYDROXAMIC ACID COMPOUNDS AS CONTRAST ENHANCERS | EASTMAN KODAK CO (US) | 2000-06-07 | — | — | EP | disclosed |
| EP-0764878-B1 | Photothermographic elements comprising hydroxamic acid developers | IMATION CORP (US) | 2000-05-24 | — | — | EP | disclosed |
| EP-0852028-A1 | BLACK-AND-WHITE PHOTOTHERMOGRAPHIC AND THERMOGRAPHIC ELEMENTS COMPRISING HYDROXAMIC ACID COMPOUNDS AS CONTRAST ENHANCERS | Imation Corp. (US) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997011410-A1 | BLACK-AND-WHITE PHOTOTHERMOGRAPHIC AND THERMOGRAPHIC ELEMENTS COMPRISING HYDROXAMIC ACID COMPOUNDS AS CONTRAST ENHANCERS | IMATION CORP. (US) | 1997-03-27 | — | — | WO | disclosed |
| EP-0764878-A1 | Photothermographic elements comprising hydroxamic acid developers | Imation Corp. (US) | 1997-03-26 | — | — | EP | disclosed |
| US-5545507-A | ULTRAHIGH CONTRAST, RESOLUTION, SHARPNESS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-08-13 | — | — | US | disclosed |
| US-4444567-A | ALKOXY BENZALDEHYDES, ALKOXY BENZOATES | PHILLIPS PETROLEUM COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4229558-A | HAVING HIGH ISOTACTIC INDEX BY USING A CATALYST PREPARED FROM A MAGNESIUM GRIGNARD REAGENT, TITANIUM HALIDE AN ETHER AND A CARBOXYLIC ESTER COMBINED WITH AN ORGANOALUMINUM COMPOUND | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1980-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | SMC4, PHOSPHO1, SMCHD1 | MAPT 21/4885RAB9A 4246/4885NPC1 2476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.